FDA's new rule on treatment use and sale of investigational new drugs.
D016638:Critical Illness; D004345:Drug Industry; D004467:Economics; D017041:Ethics Committees; D028741:Ethics Committees, Clinical; D028744:Ethics Committees, Research; D035082:Federal Government; D005249:Fees and Charges; D005251:Fees, Medical; D005378:Financial Support; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D007348:Insurance, Health; D005791:Patient Care; D018579:Patient Selection; D010361:Patients; D004364:Pharmaceutical Preparations; D012106:Research; D035842:Research Subjects; D012926:Social Control, Formal; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration
Biomedical and Behavioral Research; Legal Approach; Professional Patient Relationship